Table 3.
Nucleotide Positiona |
Nucleotide Variant |
Amino Acid Variant |
Case-Control Comparisons | Controlsd, N = 165 |
|||||
---|---|---|---|---|---|---|---|---|---|
Clefting (CL/P), n = 33* | Clefting and Tooth Agenesisb, n = 19 | Clefting and Tooth Agenesisc, n = 13 | |||||||
Number of Variantse (%) | p value | Number of Variantse (%) | p value | Number of Variantse (%) | p value | ||||
5′UTR | |||||||||
434 | −36G>A | - | 4/66 ( 6.1%) | 0.22 | 0/38 ( 0%) | 0.11 | 0/38 ( 0%) | 0.11 | 20/330 ( 6.1%) |
EXON 1 | |||||||||
570 | 101C>G | Ala34Gly | 12/66 (18.2%) | 0.14 | 16/38 (42.1%) | 0.0008 | 9/26 (34.6%) | 0.028 | 60/330 (18.2%) |
799 | 330C>T | Gly110Gly | 3/66 ( 4.5%) | 0.11 | 0/38 ( 0%) | 0.56 | 0/38 ( 0%) | 0.56 | 5/318 ( 1.6%) |
3′UTR | |||||||||
3695 | *6C>T | - | 30/66 (45.4%) | 0.001 | 4/38 (10.5%) | 0.014 | 2/26 ( 7.7%) | 0.017 | 66/248 (26.6%) |
n = number of individuals included in the analysis.
Positions of variants are referred to by the nucleotide position within the GenBank entry, AF426432.
Analysis included 19 individuals with clefting and tooth agenesis.
Analysis excluded six individuals with clefting, tooth agenesis, and additional major anomalies or facial dysmorphology.
Control data from Lidral et al. (1998).
Number of variants is number of chromosomes for rare allele/total number of alleles.